CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results
May 04, 2016 16:05 ET
|
CombiMatrix Corporation
Revenues Increase 28% to $3.0 Million on Record Reproductive Health Genetic Screening Test Volume and Higher Average Revenue per Test Conference Call Begins Today at 4:30 p.m. Eastern Time ...
CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
April 27, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close...
CombiMatrix Provides Strategic Update
April 21, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations
April 05, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing
March 29, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Closes $8.0 Million Underwritten Public Offering
March 24, 2016 09:59 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at the ROTH Conference
March 09, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
February 17, 2016 16:05 ET
|
CombiMatrix Corporation
Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test VolumesConference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif.,...
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
February 17, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
February 11, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...